Selective death of cancer cells by preferential induction of reactive oxygen species in response to (-)-epigallocatechin-3-gallate

Biochemical and Biophysical Research Communications

Volumn 421, Issue 1, 2012, Pages 91-97

  Min, Na Young ^a   Kim, Jin Hong ^a   Choi, Jee Hye ^a   Liang, Wen ^a   Ko, Young Jong ^a   Rhee, Sangmyung ^a   Bang, Hyoweon ^a   Ham, Seung Wook ^a   Park, Ae Ja ^a   Lee, Kwang Ho ^a  

^a Chung Ang University   (South Korea)

Author keywords

CTCF; DNMT1; EGCG; HTERT; ROS

Indexed keywords

CATALASE; DNA METHYLTRANSFERASE 1; EPIGALLOCATECHIN GALLATE; HYDROGEN PEROXIDE; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR CTCF; TUBULIN;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL TYPE; CONTROLLED STUDY; DEMETHYLATION; DNMT1 GENE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; EPIGENETICS; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; HTERT GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CATECHIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; HCT116 CELLS; HEK293 CELLS; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84860320529     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.120     Document Type: Article

References (17)

1. Raj L., Ide T., Gurkar A.U., Foley M., Schenone M., Li X., Tolliday N.J., Golub T.R., Carr S.A., Shamji A.F., Stern A.M., Mandinova A., Schreiber S.L., Lee S.W. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011, 475:231-234.
2. Gupta S., Hussain T., Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys. 2003, 410:177-185.
3. Ahmed A., Tollefsbol T.O. Telomerase, telomerase inhibition, and cancer. J. Anti. Aging Med. 2003, 6:315-325.
4. Kyo S., Takakura M., Fujiwara T., Inoue M. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci. 2008, 99:1528-1538.
5. Mittal A., Pate M.S., Wylie R.C., Tollefsbol T.O., Katiyar S.K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol. 2004, 24:703-710.
6. Berletch J.B., Liu C., Love W.K., Andrews L.G., Katiyar S.K., Tollefsbol T.O. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell. Biochem. 2008, 103:509-519.
7. Choi J.H., Min N.Y., Park J., Kim J.H., Park S.H., Ko Y.J., Kang Y., Moon Y.J., Rhee S., Ham S.W., Park A.J., Lee K.H. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. Biochem. Biophys. Res. Commun. 2010, 391:449-454.
8. Ballatori N., Krance S.M., Notenboom S., Shi S., Tieu K., Hammond C.L. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009, 390:191-214.
9. Zinn R.L., Pruitt K., Eguchi S., Baylin S.B., Herman J.G. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 2007, 67:194-201.
10. Renaud S., Loukinov D., Abdullaev Z., Guilleret I., Bosman F.T., Lobanenkov V., Benhattar J. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res. 2007, 35:1245-1256.
11. Ishihara K., Sasaki H. An evolutionarily conserved putative insulator element near the 3' boundary of the imprinted Igf2/H19 domain. Hum. Mol. Genet. 2002, 11:1627-1636.
12. Jensen D.E., Black A.R., Swick A.G., Azizkhan J.C. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell. Biochem. 1997, 67:24-31.
13. Hastak K., Agarwal M.K., Mukhtar H., Agarwal M.L. Ablation of either p21 or bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J. 2005, 19:789-791.
14. Lin R.K., Wu C.Y., Chang J.W., Juan L.J., Hsu H.S., Chen C.Y., Lu Y.Y., Tang Y.A., Yang Y.C., Yang P.C., Wang Y.C. Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer. Cancer Res. 2010, 70:5807-5817.
15. Tan H.H., Porter A.G. P21(WAF1) negatively regulates DNMT1 expression in mammalian cells. Biochem. Biophys. Res. Commun. 2009, 382:171-176.
16. Li G.X., Chen Y.K., Hou Z., Xiao H., Jin H., Lu G., Lee M.J., Liu B., Guan F., Yang Z., Yu A., Yang C.S. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 2010, 31:902-910.
17. Lee W.J., Shim J.Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68:1018-1030.